News
2019-10-08: Genovis Launches GlyCLICK 2 mg
GlyCLICK is a site-specific conjugation technology for IgG using enzymatic remodeling of the Fc-glycans and click-chemistry. The GlyCLICK technology is available in a range of kit formats to facilitate tailored and site-specific labeling of antibodies. GlyCLICK for azide activation of 2 mg of antibody is available for purchasing today.
2018-04-26: Genovis Launches GlycOCATCH™
GlycOCATCH is an enrichment resin for affinity purification of O-glycosylated proteins and peptides. The resin is designed to bind proteins and peptides carrying O-glycans with high affinity, and it is provided in convenient spin columns to allow easy-to-use O-glycoprotein enrichment. The GlycOCATCH product is available for purchasing today.
Antibody Glycation Study using Intact LC-MS
IgGZERO is starring a newly published study demonstrating the use of intact mass spectrometry to determine the level of glycation on therapeutic antibodies. To perform the assay, IgGZERO was used to rapidly remove the Fc-glycans.
A New Assay to Study Antibody Disulphide Bonds using FabRICATOR and FabALACTICA
In a recently published article, FabRICATOR was used to digest below the hinge and FabALACTICA above the hinge of human IgG1, generating three fragments; the hinge peptide, the Fab and the Fc/2 fragments. This setup enables analysis of both inter- and intrachain disulphide bonds, as well as other quality attributes.
